These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20132919)

  • 1. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
    Vincent AL; Ciacci-Zanella JR; Lorusso A; Gauger PC; Zanella EL; Kehrli ME; Janke BH; Lager KM
    Vaccine; 2010 Mar; 28(15):2782-7. PubMed ID: 20132919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vaccine; 2011 Mar; 29(15):2712-9. PubMed ID: 21310191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates.
    Kitikoon P; Vincent AL; Janke BH; Erickson B; Strait EL; Yu S; Gramer MR; Thacker EL
    Vaccine; 2009 Dec; 28(2):523-31. PubMed ID: 19837089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
    Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
    Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus.
    Loeffen WL; de Vries RP; Stockhofe N; van Zoelen-Bos D; Maas R; Koch G; Moormann RJ; Rottier PJ; de Haan CA
    Vaccine; 2011 Feb; 29(8):1545-50. PubMed ID: 21219983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.
    Said A; Lange E; Beer M; Damiani A; Osterrieder N
    Virus Res; 2013 May; 173(2):371-6. PubMed ID: 23333290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.
    Laurie KL; Carolan LA; Middleton D; Lowther S; Kelso A; Barr IG
    J Infect Dis; 2010 Oct; 202(7):1011-20. PubMed ID: 20715930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
    Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
    Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine.
    Babiuk S; Masic A; Graham J; Neufeld J; van der Loop M; Copps J; Berhane Y; Pasick J; Potter A; Babiuk LA; Weingartl H; Zhou Y
    Vaccine; 2011 Apr; 29(17):3118-23. PubMed ID: 21382482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
    Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
    Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
    Kitikoon P; Vincent AL; Jones KR; Nilubol D; Yu S; Janke BH; Thacker BJ; Thacker EL
    Vet Microbiol; 2009 Nov; 139(3-4):235-44. PubMed ID: 19595522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS; Gramer MR; Barbé F; Van Doorsselaere J; Van Reeth K
    Vet Microbiol; 2010 Jul; 144(1-2):67-74. PubMed ID: 20116942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
    Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME
    Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.